Enfermedad de Wilson de manifestación tardía

Campos Franco, J; Domínguez Santalla, M. J; Tomé Martínez de Rituerto, S; Otero Antón, E; González Quintela, A.
An. med. interna (Madr., 1983) ; 20(8): 416-418, ago. 2003.
Artículo en Es | IBECS (España) | ID: ibc-23860

Documentos relacionados

  1. Penicillamine-induced degenerative dermopathy in a patient with Wilson's disease.
  2. Neurological worsening in Wilson disease - clinical classification and outcome.
  3. Significant heterogeneity in the diagnosis and long-term management of Wilson disease: Results from a large multicenter Spanish study.
  4. Challenging diagnosis of Wilson's disease: A case report.
  5. Pregnancy Outcomes in Wilson's Disease Women: Single-Center Case Series.
  6. ATP7B Genotype and Chronic Liver Disease Treatment Outcomes in Wilson Disease: Worse Survival With Loss-of-Function Variants.
  7. [An introduction to multidisciplinary recommendations for Wilson's disease comprehensive diagnosis and management: 2022 practice guidance from the American Association for the Study of Liver Diseases].
  8. Relapse following withdrawal of D-penicillamine from combination (D-penicillamine + zinc) therapy in hepatic Wilson disease.
  9. Wilson's disease - a tricky diagnosis on the acute take.
  10. Experience on switching trientine formulations in Wilson disease: Efficacy and safety after initiation of TETA 4HCl as substitute for TETA 2HCl.